Texas Children’s and MD Anderson receive $150M gift from Kinder Foundation to launch Kinder Children’s Cancer Center

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

Democratic leaders of the House Committee on Energy and Commerce are urging NIH Director Jay Bhattacharya to voice objections to a proposed rule from the Office of Management and Budget that would give the administration unprecendented political control over government-funded science.

MD Anderson’s Vincent Bernard receives Project Purple’s Research Recovery Grant for pancreatic cancer research

Project Purple has awarded a $375,000 Research Recovery Grant to researchers at the University of Texas MD Anderson Cancer Center to continue critical pancreatic cancer research.

June 26, 2026

Vol.52 No.25

Funding Opportunities

The Foundation for AIDS Research opens RFP to fund non-HIV cancer research

Historically, the research initiatives of the Foundation for AIDS Research (amfAR) have focused on finding a cure for HIV. Four decades of HIV research have reshaped our understanding of the immune system, and insights from HIV have been leveraged in adjacent fields, including cancer immunology. Innovation can be bi-directional and reciprocal. Seminal findings in cancer immunology have also furthered understanding of HIV biology.

June 26, 2026

Vol.52 No.25

Capitol Hill

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

On June 9, the House Appropriations Committee passed its version of the fiscal year 2027 spending bill for Labor, Health and Human Services, and Education.

June 12, 2026

Vol.52 No.23

By Paul Goldberg

Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final

The White House Office of Management and Budget has released a 412-page proposal that inserts political appointees into all stages of reviewing and awarding of federal research grants.

June 05, 2026

Vol.52 No.22

By Paul Goldberg and Claire Marie Porter

In Brief

Giulio Draetta, former MD Anderson CSO, center director joins privately held Orionis Biosciences

Giulio Draetta was recently named chief strategy officer at Orionis Biosciences, a privately held, clinical stage life sciences company focused on discovery, design, and development of precision medicines for cancer and immune system-related disorders. Orionis is based in Boston and Ghent, Belgium.

May 29, 2026

Vol.52 No.21

Texas Children’s and MD Anderson receive $150M gift from Kinder Foundation to launch Kinder Children’s Cancer Center

YOU MAY BE INTERESTED IN

OMB draft rule politicizing research should be rescinded, House Dems urge in a letter to Bhattacharya

MD Anderson’s Vincent Bernard receives Project Purple’s Research Recovery Grant for pancreatic cancer research

The Foundation for AIDS Research opens RFP to fund non-HIV cancer research

House bill gives NCI $7.4 billion in FY 2027—$110 million above current budget

Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final

Giulio Draetta, former MD Anderson CSO, center director joins privately held Orionis Biosciences

Renew today!

Subscriber content

Never miss an issue!

Login